A.L. Labs
This article was originally published in The Tan Sheet
Executive Summary
Generic firm's NMC Laboratories subsidiary gains FDA approval for an ANDA covering clotrimazole 1% cream for the treatment of vaginal yeast infections. In a July 23 announcement, A.L. Labs noted that NMC's clotrimazole is the "only generic equivalent to" Schering-Plough's Gyne-Lotrimin. NMC expects to begin marketing the clotrimazole product in the fourth quarter. NutraMax also is slated to begin shipping a private label clotrimazole cream and insert in the late fall under a deal with an undisclosed supplier ("The Tan Sheet" July 12, In Brief).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning